CG Oncology (CGON) Change in Inventory (2025 - 2026)

CG Oncology posted quarterly Change in Inventory of -$72000.0 for Q1 2026, down 212.5% on a QoQ basis from $64000.0 in Q4 2025.

CG Oncology (CGON) has 2 years of Change in Inventory data on file, last reported at -$72000.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 665.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 97.70 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -26.60 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3.32 Mn
10 CG Oncology 5.01 Bn 5.01 Bn -1.88 Mn -72,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -72,000.00
Mar 31, 2026 -72,000.00
Dec 31, 2025 64,000.00
Dec 31, 2025 64,000.00